Timothy R. Lubenow MD

Timothy R. Lubenow MD

Timothy R. Lubenow MD

Academic Positions

Adjunct Professor of Anesthesiology, 1987 – 1988

Assistant Professor of Anesthesiology, 1988 – 1995

Associate Professor of Anesthesiology, 1995 – 2004

Professor of Anesthesiology, Rush Medical College, 2004 to present

 

Education

  • Medical College of Wisconsin, Milwaukee, WI, M.D., 1983

 

Memberships

  • American Society of Anesthesiologists
  • Illinois Society of Anesthesiologists
  • Chicago Society of Anesthesiologists
  • American Medical Association
  • Illinois State Medical Society
  • Chicago Medical Society
  • American Society of Regional Anesthesia and Pain Medicine
  • ASRAPM Neuromodulation Special Interest Group
  • International Association for the Study of Pain
  • American Society of Interventional Pain Physicians
  • Illinois Society of Interventional Pain Physicians
  • Rush Surgical Society
  • Association of Anesthesia Pain Program Directors
  • North American Neuromodulation Society
  • Society of Academic Anesthesia Associations – Subspecialty Program Directors

 

Editorial Boards

  • Consulting Reviewer, The Clinical Journal of Pain, 1991 – 1996
  • Editorial Board, The Pain Journal Club Journal, 1995 – 2000
  • Consulting Reviewer, Neuromodulation, 2007 – 2013
  • Editorial Board, Pain Physician, 2008 – 2014
  • Editorial Board, Regional Anesthesia and Pain Medicine 2015 to present

 

Hospital Committees

  • Committee on Committees – Secretary 1988 – 1989
  • Surgical and Invasive Procedure Review Committee, 1993 – 2008
  • Surgical Utilization Management Subcommittee, 1995 – 2008
  • Pain Clinical Pathway Committee, 1995 – 1996
  • PCA Clinical Pathway Committee, Chair, 1997 – 1999
  • Global Pain Initiative Committee, Co-chair, 1999 – 2005
  • Graduate Medical Education Committee, 1995 to present
  • Total Joint Arthroplasty Clinical Pathway Committee, 1998 – 2015
  • Physician's Assistance Committee 2003 – 2006
  • Rush Surgicenter Finance Committee 2003 – present

 

Current Research

A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Precision Spinal Cord Simulating System Adapted for High Rate Spinal Cord Stimulation.

 

81 Peer Reviewed Publications

Research Grants

  • Development of Pain Management Provider Epidural Pump 1991 (Abbott Labs)
  • A Multicenter Open Label Study of the Safety and Tolerability of Sustained Release Tramadol Hydrochloride in Chronic Pain Patients, 1998-1999 Principal Investigator (Purdue Pharma Grant $57,000) – Completed
  • Multicenter, Blinded, Randomized, Placebo Controlled Study of 0.05% Clonidine Gel in Patients with Post-Herpetic Neuralgia, 1999 (Curatek Pharmaceuticals; Grant: $50,000 Principal Investigator) – Completed
  • Multicenter, Blinded, Randomized, Placebo Controlled Study of 0.05% Clonidine Gel in Patients with Post-Diabetic Neuralgia, 1999 (Curatek Pharmaceuticals; Grant: $50,000 Principal Investigator) – Completed
  • Safety, efficacy and impact of quality of long term administration of Dilaudid CR for patients with chronic low back pain, 1999 (Knoll Pharma; Grant: $65,000, Co-investigator) – Completed
  • Pain Medicine Data Bank for the Rush Pain Clinic at Rush University, 1999 (Roxane, Grant: $25,000, Co-investigator) – Completed
  • National Data Bank on Advanced Pain Therapy for Low Back Pain, 1999 – 2001 Grant: $3,000 (Medtronic, Principal Investigator) – Completed
  • A prospective clinical trial to evaluate the cerebrospinal fluid and plasma pharmacokinetics of rofecoxib with single and multiple oral drug administration in subjects with implanted drug pumps with sampling side ports and lumbar intrathecal catheters for the control of chronic pain. (PI: Merck Medical School Grant: $78,000)
  • A randomized placebo controlled study comparing efficacy of Hydromorphone HCL extended release and Duragesic in subjects with non-malignant pain. Co-investigator (Purdue Pharma) 2003.
  • Double blind multicenter study of the efficacy of Parecoxib followed by Valdecoxib compared to placebo in general surgery patients for the treatment of post-surgical pain. Co-investigator (Pharmacia) – Completed
  • Randomized, double-blind active controlled study of the safety and efficacy of SKY0404 (Propofol 2%) versus Diprivan injectable emulsion 1% in balanced anesthesia. Co-investigator (SkyPharma) – Completed
  • Study on analgesic efficacy safety and tolerability of AR-P900758XX a six week randomized double blind placebo-controlled dose finding multicenter study comparing AR-P900758XX with Vioxx and with Naproxen in subjects with Osteoarthritis of the Knee Co-investigator (Astra-Zeneca), 2002.
  • Double blind study of the efficacy and safety of a single dose of IV Parecoxib sodium followed by seven days of oral Valdecoxib for the pain following laparoscopic cholecystectomy. Co-Investigator (Pharmacia; Grant $16,000) 2001 – Completed
  • The safety and efficacy of Electrotransport (E-TRANS) Fentanyl compared to IV PCA Morphine for the treatment of postoperative pain. Principal investigator (Alza; Grant: $120,000) 2000 – Completed
  • An open evaluation of safety and clinical utility of E-TRANS (fentanyl) for management of postoperative pain in children and adolescents. Co-investigator (Alza; Grant $100,000) 2000 – Completed
  • A Randomized, Double-Blinded, Placebo–Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. ELN92045-301. Grant $43,020.00. Principal Investigator–completed.
  • Restore™ Spinal cord Stimulation characterization study. Principal Investigator (Medtronic: Grant $121,000) 2005 – 2006 completed
  • Prism™ Occipital nerve stimulation for migraine Principal Investigator (Boston Scientific) completed 2006-2013
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTabĀ® PCA System/15 mcg for the Treatment of Post-Operative Pain in Patients after Open Abdominal Surgery. ( Pharmanet) 2013 – 2014 Completed
  • A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Precision Spinal Cord Simulating System Adapted for High Rate Spinal Cord Stimulation Principal Investigator ( Boston Scientific 2014- present)
  • 1A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I) Principal Investigator. (Axesome Therapeutics 2016 - present)
  • Data Collection Study of CRPS Patients Undergoing DRG Implant . Principal Investigator. ( Departmental 2016 to present)
  • TARGET: A Post-Approved Study to Evaluate Targeted SCS (DRG) Stimulation for the Managmeent of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs due to CRPS Types I and II. Principal Investigator. ( St. Jude Medical 2016- present)
  • Open-Label Safety Trial of Intravenous Neridronic Acid in Subjects with Complex Regional Pain Syndrome (CRPS). Principal Investigator. ( Grunenthal 2016- present)
  • Improving functional outcomes and lowering health care costs by enhanced integration of primary care providers and pain medicine physicians for the management of chronic non–cancer pain patients. (PCP/PMS) Sub Investigator. (Pfizer/Departmental 2015 to present)
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery. Sub Investigator (Trevena 2015 – present)
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating The Analgesic Efficacy and Safety of Intraveous CR845 In Patients Undergoing Abdominal Surgery. Sub Investigator ( Kimberly Clark/ Halyard Medical 2015 to present )